Neurocycle Therapeutics is developing drugs that regulate neuron signaling. Our lead candidate NCT-10004 is being developed for treatment of itch in people and dogs. In addition, we have drug discovery programs in pain and orphan epilepsies.
Neurocycle Therapeutics is developing drugs that regulate neuron signaling. Our lead candidate NCT-10004 is being developed for treatment of itch in people and dogs. In addition, we have drug discovery programs in pain and orphan epilepsies.